Sickle cell disease trials in France
10 of 39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleDevelopment of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
- Where
- Paris
- Age
- 18 years and over
- People
- 550
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06147414 - No phaseNot yet taking people in FranceComparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell Disease Depending on Their SS or SC Genotype (DrepAgreg)
- Where
- Bobigny
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Centre Hospitalier Universitaire de la Guadeloupe
See details and how to joinNCT07852442 - No phaseNot yet taking people in FranceEpidemiology of Invasive Bacterial Infections in Children With Sickle Cell Disease in France Between 2020 and 2025
- Where
- Argenteuil, Aulnay-sous-Bois, Bondy, Bordeaux, Boulogne-Billancourt, Bry-sur-Marne, Cergy-Pontoise, Clamart, Corbeil-Essonnes, Créteil, Fontainebleau, Gonesse, Jossigny, Le Kremlin-Bicêtre, Mantes-la-Jolie, Marseille, Meaux, Melun, Montfermeil, Nantes, Neuilly-sur-Seine, Nice, Orsay, Paris, Poissy, Rambouillet, Saint-Denis, Versailles, Villeneuve-Saint-Georges
- Age
- Up to 17 years
- People
- 350
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07639008 - No phaseTaking peopleStudy of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA
- Where
- Reims
- Age
- 2 years to 18 years
- People
- 29
- Run by
- CHU de Reims
See details and how to joinNCT06581900 - No phaseTaking peoplePhysiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations
- Where
- Clichy, Paris
- Age
- 18 years and over
- People
- 100
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06418256 - No phaseNot yet taking people in FranceTransfusion Exchanges and Cognition in Sickle Cell Disease
- Where
- Bobigny, Créteil, Le Kremlin-Bicêtre, Paris, Saint-Denis
- Age
- 18 years and over
- People
- 85
- Run by
- Centre Hospitalier St Anne
See details and how to joinNCT07168447 - Phase 3Enrolling by invitationLong-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy
- Where
- Paris
- Age
- 2 years to 53 years
- People
- 85 worldwide
- Run by
- Genetix Biotherapeutics Inc.
See details and how to joinNCT04628585 · EU 2024-513901-30-00 - No phaseTaking peoplePhenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient
- Where
- Toulouse
- Age
- 18 years and over
- People
- 40
- Run by
- University Hospital, Toulouse
See details and how to joinNCT06887907 - No phaseNot yet taking people in FranceRelationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation
- Where
- Lyon
- Age
- 8 years and over
- People
- 200
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT06619093 - No phaseNot yet taking people in FranceEvaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease
- Where
- Toulouse
- Age
- 18 years and over
- People
- 20
- Run by
- University Hospital, Toulouse
See details and how to joinNCT06769139